A B S T R A C T Radiation therapy to either mediastinum or pelvis causes a rapid decrease in circulating lymphocytes of both B and T types and in addition an impairment in the function of the remaining lymphocytes, as measured by their ability to proliferate in response to mitogens. The acute depression is short-lived. Substantial recovery is apparent within 3 wk after cessation of therapy; however, most patients show a modest, chronic depression in both numbers and functional capacities of circulating lymphocytes. T cells are somewhat more sensitive than B cells, but both are affected.
INTRODUCTION
In experimental situations in vitro, thymus-derived (T) lymphocytes and antibodies (the product of bone marrow-derived lymphocytes), in conjunction with "non-T" cells or complement, can destroy tumor cells (1) (2) (3) (4) . In virtually every case of clinical cancer, these mechanisms are inadequate to eradicate an established tumor, as "spontaneous" regressions are very rare. Nevertheless, it is possible that the degree of competence of a patient's immune system may be an important factor in the clinical course of his disease. For this reason, it is important to examine (a) the immunosuppressive effects of various modalities of cancer therapy, and (b) the correlation, if any, of such immunosuppression with prognosis.
In this study, we have examined prospectively the effects of radiation therapy (RT)' delivered to the mediastinal area, including the thymus, on the numbers and functional capacities of certain subpopulations of circulating lymphocytes. In particular, we have tried to test the hypothesis that irradiation of the thymus per se can decrease the numbers and impair the function of circulating T lymphocytes (5) . Patients receiving pelvic irradiation serve as a good control group because they receive a similar dose of radiation to tissue and blood without thymic irradiation. Patients were evaluated before, during, and after therapy.
To identify the subclasses of lymphocytes, we used three methods: rosette formation, membrane immunofluorescence (MF), and blastogenic response to mitogens. Approximately 60% of human peripheral blood lymphocytes (PBL) and 95% of human thymocytes form spontaneous rosettes with sheep red blood cells (E 'Abbreviations used in this piper: A, rabbit hemolysin; C, human complement; CRL, complement-receptor lympho- rosettes). They are thought to represent human T lymphocytes, both mature and immature (6, 7) . E rosettes prepared by another method have been said to correlate with cell-mediated immune competence (8) . Approximately 30% of human peripheral blood mononuclear cells have been shown to have receptors for activated complement on their surface. Most of the complement-receptor lymphocytes (CRL) belong to the antibody-forming or B cell line, while a few are monocytes (9) (10) (11) . To demonstrate CRL ("B cells"), EAC rosettes are made with sheep erythrocytes (E) coated with a nonagglutinating concentration of rabbit hemolysin (A) and human complement (C) (9, 12) .
T and B cells can also be distinguished by their membrane-associated antigens. T cells have, on their surface, antigen(s) cross-reactive with brain tissue both in mice (13) and in man (14, 15) . B cells have surface immunoglobulin easily detectable by immunofluorescence (16, 17) . We have used direct and indirect MF to enumerate cells bearing on their surface either immunoglobulin (most B cells) or an antigen cross-reactive with brain (T cells). In addition, we have used a human autoantibody to identify T cells (18) .
METHODS
The 21 patients receiving radiation therapy in this study were treated by the Varian 6 meV accelerator, half value layer 18 mm Cu at a target to skin distance of 100 cm (Varian Associates, Palo Alto, Calif.). All patients were treated with five fractions per week. Treatment ports for patients with breast carcinoma were planned in accordance with the National Surgical Adjuvant Breast Protocol (NSABP) study 4, which compares radical mastectomy with total (simple) mastectcmy with or without RT as therapy for primary stage I and II cancers. This plan includes irradiation of the chest wall, internal mammary, and supraclavicular and axillary lymphatics, after simple mastectomy. The entire esophagus of the one patient with carcinoma of the esophagus was treated with one anterior and two posterior oblique fields. (21) , and the E-RFC were counted. Note that the ratio of SRBC to mononuclear cells is very high (> 100: 1), the suspension is incubated in HBSS at 370C, and the rosettes are kept cold overnight. This gives stable rosettes, and nearly all normal subjects' T-cells form E-rosettes. "Active" E-RFC (a T-cell subpopulation?) were prepared by the method of Wybran, Carr, and Fudenberg (22) . To wit, 0.5 X 106 mononuclear cells in 0.1 ml HBSS and 0.1 ml sterile FBS (absorbed with SRBC and agarose) were mixed and incubated at 370 for 1 h. SRBC were added (eight per lymphocyte in 0.1 ml HBSS) and the suspension The number of RFC was determined by both a "fresh" count and (for E and EAC rosettes) a fixed slide count. The fresh counts were performed with the aid of a vital stain. One drop of a 1: 2 dilution of 1% toluidene blue (23) in methanol, previously dried on the bottom of a 12 X 75-mm glass tube, was redissolved in 0.1 ml of saline; 0.2 ml of the RFC suspension was carefully added, and within 1-3 min, the suspension was gently mixed, a portion placed on a hemocytometer, and an area of 4 mm2 scored. Mononuclear cells were scored "+" (four or more SRBC adherent) or "-" (three or fewer adherent SRBC); polymorphonuclear leukocytes or cells with granules were ignored. For active E-RFC, our criterion was three red blood cells attached (cf. Wybran's criterion of one attached erythrocyte; ref. 22) . The number of RFC per milliliter of peripheral blood is determined from the percent positive cells and the number of mononuclear cells present per milliliter of whole blood.
Fixed slide preparations were made by first pipetting 0. For indirect membrane fluorescence (IMF) tests (T or B cells) the lymphocytes were incubated with the antiserum diluted in HBSS for 1 h, washed as above, and resuspended in 0.2-0.3 ml of appropriately diluted fluoresceinated antiserum (see Table II ). They were incubated, washed, resuspended, and counted as above.
RESULTS
Four groups of subjects were initially studied: group A, normal laboratory and secretarial personnel; group B, patients with breast cancer who received mediastinal RT; group C, patients with breast cancer who did not receive RT; and group D, patients who received pelvic RT. In addition, one patient with esophageal and one with lung cancer who showed results like those of the other mediastinal RT patients were included in group B. Groups B and D were followed during and after RT. 16 patients (including 10 on the NSABP study) receiving prophylactic RT for breast cancer were studied.
The breast cancer controls (group C) were all on the NSABP protocol study 4, which compares radical mastectomy and simple mastectomy with or without RT in primary stage I and II tumors. The patients receiving pelvic RT comprised four cervical, three ovarian, and three endometrical carcinomas (see Table I ). Immunosuppression by Radiotherapy O---0, 10 (24) . Isolation of lymphocyte subpopulations. The yield and purity of the mononuclear cell preparations from blood of normal subjects was superior to that from patients' blood, even before RT. Contamination by polymorphonuclear leukocytes averaged 10% in normals and was significantly greater in patients both before (P < 0.05) and after (P < 0.01) RT. There was no correlation between the percent recovery and contamination with polymorphonuclear leukocytes. Greaves The treatment caused moderate lymphopenia, first evident at 1,000 rads in patients receiving pelvic and 2,000 rads in patients receiving mediastinal RT. Recovery from lymphopenia is quite variable. In some patients, recovery seemed to be complete within 1-3 wk, but then the lymphocyte count dropped again and remained low for months. A rapid decline is detected in both T and B lymphocytes during RT, when lymphocytes that form spontaneous (E) or complement receptor (EAC) rosettes are enumerated ( Fig. 3 and 4) . Active E-RFC, prepared by the method of Wybran, underwent essentially the same changes as total E-RFC (Fig. 5) . The number of T cells dropped very rapidly and profoundly during RT; a least squares estimate of the slope of the line was -2.04±0.23 for group B (mediastinal RT) and -2.74±0.42 for group D (pelvic RT). EAC-RFC decreased more slowly (P <0.01); the slope was -0.85 for both groups B and D. Cells bearing SIg dropped 50% after 2,500-5,000 rads (Table VI) . 2,500-5,000 rads 2.6±0.8 (4) <0.02 After RT (1-8 wk) 2.9±t0.9 (6) <0.05 * Number of positive lymphocytes X 105/ml of peripheral blood, mean+SEM (number of subjects). 4 Student's t test, compared versus number of positive cells before RT.
In vitro responses to mitogen stimulation. Many lymphocytes are lost during RT; in addition, those that remain in the circulation lose their ability to incorporate
[3H]TdR in response to mitogenic stimulation (Figs. 6 and 7). These tests were performed with constant numbers of mononuclear cells, so the decline in functional capacity, to the extent that this is reflected in the response to mitogens, is in addition to the decline in numbers.
During the course of RT, the [3H]TdR incorporation for "nonstimulated" cultures increases slightly. The response to PHA-P, as measured by [3H]TdR incorpora- tion, declines by the time 2,000 rads have been delivered to the mediastinum (P < 0.02) or 3,000 rads to the pelvic area (P < 0.01). More data are needed to determine if these differences in rapidity of decline are significant. At the end of treatment (approximately 5,000 rads), the response of both groups is profoundly de- pressed. The response to PWM is also reduced by RT, beginning at 2,000-3,000 rads.
Recovery of lymphocyte subpopulations after radiotherapy. Substantial recovery of total mononuclear cells and RFC is evident within 2 wk. The first phase of rapid recovery (about 3 wk) is followed by a second phase of very slow increase (Figs. 3-5 ). In some patients, especially pelvic RT patients, T cell numbers show a second decline at about 1 mo. The present data show no significant recovery of SIg-bearing cells, but this point requires further investigation (Table VI) . Recovery of functional capacity is slower than recovery of either cell number or RFC. The response to PHA-P shows a biphasic recovery curve; modest recovery is seen at 2 wk, followed by a sharp drop at 4 wk (P < 0.001 pelvic, P < 0.05 mediastinal) and a subsequent recovery at 1-3 mo (P < 0.05 pelvic, P < 0.1 mediastinal (25) . Role of thymic radiation in acute lymphopenia. One purpose of this study was to investigate the hypothesis that a radiation-induced thymic defect was responsible for changes in lymphocyte numbers and subpopulations.
For this purpose, patients who had received RT to the mediastinal and pelvic areas, respectively, were compared. Both groups showed a pronounced lymphopenia after receiving about 3,000 rads ( Fig. 2 and ref. 24 ).
Thoracic radiation of mice (2,000 rads in 5 days) caused a similar rapid but fully reversible lymphopenia (26) .
Tissues containing lymphoid cells in the treatment fields, in addition to the thymus, are blood, lymphatics, and bone marrow. It has been shown that extracorporeal irradiation of blood alone can cause profound lymphopenia (27, 28) . Pelvic RT may also expose gut-associated lymphoid tissue to radiation damage. It should also be noted that RT causes nonspecific stress, which may in itself be immunosuppressive (29, 30) .
Studies in mice have shown that irradiation of the thymus alone (one dose of 150 rads) causes no lymphopenia in mice, although it alters the proportion of small to large lymphocytes in the blood (31) . If some bone marrow is shielded during whole body irradiation, the irradiated thymus is rapidly repopulated by precursors from the bone marrow (31, 32) , unless a dose of at least 3,000 rads at one time has been delivered to the organ (33) . Thus the thymocytes killed by radiation in these patients are probably replenished rapidly. Circulating T cells, however, seem to be depleted for a longer time.
Comparison of the patients receiving pelvic and mediastinal RT indicates that the alterations in lymphocyte numbers are similar in the two groups. This does not support the inference from the work of Stjernsward, Jondal, Vanky, Wigzell, and Sealy (5) that irradiation of the thymus per se is the primary cause of the alteration in circulating lymphocyte populations. It is clear that thymic radiation is not responsible for acute lymphopenia.
Relative radiosensitivity of various lymphocyte subpopulations. When subpopulations of circulating lymphocytes are enumerated during RT, T cells appear to be more radiosensitive than B cells. A decrease in both T and B cells can first be detected between 1,000 and 2,000 rads. When the number of T and B rosettes is plotted against radiation dose (least mean squares method) the slope of the T cell decrease is significantly greater than that of the B cells (P < 0.01). The measurement of small numbers of B cells by the EAC rosette technique is subject to question because of possible confusion with monocytes, which also bear complement receptors (11) , but the conclusion is borne out by studying a second B cell marker, SIg. The ratio of T to B cells fell significantly in patients receiving both pelvic and mediastinal RT; the overall loss during RT was 85% of E rosettes, but only 75% of EAC rosettes, and 60% of cells bearing SIg. (See also Results: Isolation of lymphocyte subpopulations). Such a decrease in ratio was originally shown by Stjernsward et al. (5) .
The ability of lymphocytes to synthesize DNA on mitogen stimulation is quite radiosensitive. Although methods have varied and results differed, most workers agree that RT causes a decrease in the response to mitogens (5, (34) (35) (36) (37) (38) . A few have found that RT does not effect the lymphocyte response to mitogens (37, 39, 40) . The time after cessation of RT at which the mitogen stimulation is measured is crucial (see Fig. 6-7) .
Since both T and B cells show substantial partial recovery within 2-3 wk after the end of therapy (34; and our unpublished data), studies of chronic post-therapy depression cannot be compared directly with studies of acute depression. In general, workers who have found little or no decrease in function have measured the response at 72 h by morphological transformation (37, 39) or thymidine incorporation (39) , while those finding depression have measured thymidine incorporation at later times. It may be that there exist, in the blood of patients after RT, radiation-damaged cells that can form rosettes, transform to blasts, and incorporate thymidine, but that die after a few days. It has been shown that morphological transformation may not correlate with
['H]TdR incorporation (39).
The decrease in ability to synthesize DNA in response to mitogen stimulation is much greater than the decrease in number of lymphocytes during RT. The response of a constant number of isolated lymphocytes to stimulation with PHA or PWM is markedly decreased by 3,000-5,000 rads ( Fig. 7-8 ). Using whole blood cultures in which the number of lymphocytes was not held constant, Jenkins, Olson, and Ellis (36), who studied lung cancer patients during and after RT, also found that the DNA synthetic capacity decreased more than the lymphocyte count.
It appears that the acute decrease in numbers of T and B lymphocytes induced by local RT and the decreased capacity of the remaining blood lymphocytes to divide in response to mitogens are caused by irradiation of lymphocytes in the recirculating pool, rather than by thymic irradiation. On the basis of these studies of acute radiation-induced lymphopenia, we can tentatively conclude that thymic shielding without changing the overall dose of radiation is unlikely to modify the acute lymphopenia induced by mediastinal irradiation.
